미국 · 보도자료 · NTRA · 2026-10-06 12:00
나테라, 방사선종양학회서 Signatera 임상 데이터 발표
AUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced new data recently shared at the American Society for Radiation Oncology (ASTRO) 2026 Annual Meeting. The presentations marked Natera’s first participation at ASTRO and a significant step in demonstrating Signatera’s role in treatment response monitoring and risk str
